Economic burden of moderate to severe irritable bowel syndrome with constipation in six European countries


Por: Tack, J, Stanghellini, V, Mearin, F, Yiannakou, Y, Layer, P, Coffin, B, Simren, M, Mackinnon, J, Wiseman, G, Marciniak, A, Bouchoucha, Ducrotte, Macaigne, Mion, Schneider, Le Sidanier, Tardy, Zerbib, Andresen, Bischoff, Jander, Jung, Krammer, Langhorst, Omankowsky, Schiefke, Steuer, Van der Voort, Von Arnim, Annese, Cuomo, De Angelis, Di Mario, Di Stefano, Ferrini, Gasbarrini, Giaccobe, Marchi, Marzio, Repici, Savarino, Angos, Berdier, Brotons, Caballero-Plasencia, Clave, Fort, Garcia, Gomez, Martinez, Perello, Rey, Sanchez-Antolin, Serra, Tantina, Toran, Ekesbo, Hellstrom, Kjellstrom, Lindberg, Walter, Arebi, Bridger, Butt, Emmanuel, Eugenicos, Kaushik, Millar, Sanders, Whorwell

Publicada: 7 may 2019
Resumen:
BackgroundIrritable bowel syndrome with predominant constipation (IBS-C) is a complex disorder with gastrointestinal and nervous system components. The study aim was to assess the economic burden of moderate to severe IBS-C in six European countries (France, Germany, Italy, Spain, Sweden and the UK).MethodsAn observational, one year retrospective-prospective (6months each) study of patients diagnosed in the last five years with IBS-C (Rome III criteria) and moderate to severe disease at inclusion (IBS Symptom Severity Scale score175). The primary objective was to assess the direct cost to European healthcare systems.ResultsFive hundred twenty-five patients were included, 60% (range: 43.1-78.8%) suffered from severe IBS-C. During follow-up 11.1-24.0% of patients had a hospitalisation/emergency room (ER) visit, median stay range: 1.5-12.0days and 41.1-90.4% took prescription drugs for IBS-C. 21.4-50.8% of employed patients took sick leave (mean: 11.6-64.1days). The mean annual direct cost to the healthcare systems was Euro937.1- Euro2108.0. The total direct cost (combined costs to healthcare systems and patient) for IBS-C was Euro1421.7-Euro2487.1.ConclusionsIBS-C is not a life-threatening condition; however, it has large impact on healthcare systems and society. Direct and indirect costs for moderate to severe IBS-C were high with the largest direct cost driver being hospitalisations/ER visits.

Filiaciones:
Tack, J:
 Univ Hosp Gasthuisberg, Leuven, Belgium

 Univ Leuven, Herestr 49, B-3000 Leuven, Belgium

Stanghellini, V:
 Univ Hosp S Orsola, Bologna, Italy

Mearin, F:
 Ctr Med Teknon, Barcelona, Spain

Yiannakou, Y:
 Cty Durham & Darlington NHS Trust, Durham, England

Layer, P:
 Israelitic Hosp, Hamburg, Germany

Coffin, B:
 Louis Mourier Hosp, AP HP, Colombes, France

 Paris Diderot Univ, Paris, France

Simren, M:
 Sahlgrens Univ Hosp, Gothenburg, Sweden

Mackinnon, J:
 TFS Develop SL, Barcelona, Spain

Wiseman, G:
 Allergan Int, Marlow, Bucks, England

Marciniak, A:
 Allergan Int, Marlow, Bucks, England

Bouchoucha:
 Hop Avicenne, Bobigny, France

Ducrotte:
 Hop Charles Nicolle, Rouen, France

Macaigne:
 Hop Lagny, Lagny, France

Mion:
 Hop Edouard Herriot, Lyon, France

Le Sidanier:
 Hop Dupuytren, Limoges, France

Zerbib:
 Hop St Andre, Bordeaux, Germany

Andresen:
 Israelitic Hosp, Hamburg, Germany

Bischoff:
 Univ Hohenheim, Stuttgart, Germany

Jander:
 Arzt Innere Med, Neuotting, Germany

Jung:
 Praxis Dr Thomas Jung, Deggingen, Germany

Krammer:
 Enddarmzentrum Mannheim, Mannheim, Germany

Langhorst:
 Kiiniken Essen Mitte, Essen, Germany

Omankowsky:
 Praxis Dr S Omankowsky, Berlin, Germany

Schiefke:
 Eurogastro, Leipzig, Germany

Steuer:
 Praxis Dr Steuer, Hemsbach, Germany

Van der Voort:
 Martin Luther Krankenhausbetrieb, Berlin, Germany

Von Arnim:
 Univ Klinikum Magdeburg, Klin Gastroenterol & Hepatol, Magdeburg, Italy

Annese:
 Careggi Univ, Florence, Italy

Cuomo:
 Univ Napoli Federico II, Naples, Italy

De Angelis:
 Univ Parma, Parma, Italy

Di Mario:
 Osped S Maria di Ca Foncello, Treviso, Italy

Di Stefano:
 Policlin San Matteo, Pavia, Italy

Ferrini:
 F Renzetti Hosp, Lanciano, Italy

Gasbarrini:
 Catholic Univ, Gemelli Hosp Rome, Rome, Italy

Giaccobe:
 Univ Messina, Messina, Italy

Marchi:
 Univ Pisa, Pisa, Italy

Marzio:
 Univ Pescara, Pescara, Italy

Repici:
 Humanitas Hosp IRCS, Milan, Italy

Savarino:
 Univ Genoa, Genoa, Spain

Angos:
 Clin Univ Navarra, Pamplona, Spain

Berdier:
 CAP Vallcarca St Gervasi, Barcelona, Spain

Brotons:
 CAP Sardenya, Barcelona, Spain

Caballero-Plasencia:
 Clin Dr Caballero, Granada, Spain

Clave:
 Hosp Mataro, Mataro, Spain

Fort:
 Hosp Dr Josep Trueta, Girona, Spain

Garcia:
 Hosp Univ Tajo, Madrid, Spain

Gomez:
 Hosp USP Sagrado Corazon, Seville, Spain

Martinez:
 Hosp St Joan Reus, Reus, Spain

Perello:
 Hosp Viladecans, Viladecans, Spain

Rey:
 Hosp Clin San Carlos, Madrid, Spain

Sanchez-Antolin:
 Hosp Univ Rio Hortega, Valladolid, Spain

Serra:
 Hosp Badalona Germans Trias & Pujol, Badalona, Spain

Tantina:
 CAP Centelles, Centelles, Spain

Toran:
 CAP Mareseme, Mataro, Sweden

Ekesbo:
 Capio Citykliniken Malmo, Malmo, Sweden

Hellstrom:
 Lakarhuset Hotorget City, Stockholm, Sweden

Kjellstrom:
 Aleris Specialistvard Sabbatsberg, Stockholm, Sweden

Lindberg:
 Karolinska Inst, Stockholm, Sweden

Walter:
 Linkoping Univ, Linkoping, Sweden

Arebi:
 St Marks Hosp, Harrow, Middx, England

Bridger:
 Dorset Cty Hosp, Dorchester, England

Butt:
 South Tyneside NHS Fdn Trust, South Shields, England

Emmanuel:
 Univ Coll Hosp, London, England

Eugenicos:
 Western Gen Hosp, Edinburgh, Midlothian, Scotland

Kaushik:
 Royal Blackburn Hosp, Blackburn, Lancs, England

Millar:
 North Middlesex Univ Hosp NHS Trust, London, England

Sanders:
 Royal Hallamshire Hosp, Sheffield, S Yorkshire, England

Whorwell:
 Wythenshawe Hosp, Manchester, Lancs, England
ISSN: 1471230X





BMC GASTROENTEROLOGY
Editorial
BMC, CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND, Reino Unido
Tipo de documento: Article
Volumen: 19 Número:
Páginas:
WOS Id: 000467407000001
ID de PubMed: 31064345
imagen gold, Green Published

MÉTRICAS